In silico identification of genetically attenuated vaccine candidate genes for Plasmodium liver stage

Infection, Genetics and Evolution

Volumn 36, Issue , 2015, Pages 72-81

  Kumar, Hirdesh ^a,b   Frischknecht, Friedrich ^b   Mair, Gunnar R ^b   Gomes, James ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

GAPs; Ortholog based analysis; Plasmodium liver stage; Vaccine

Indexed keywords

LIVE VACCINE; PROTEOME; TRANSCRIPTOME; MALARIA VACCINE; PROTOZOAL PROTEIN;

ARP GENE; ARTICLE; COMPUTER MODEL; FABB GENE; FABF GENE; FABI GENE; GENE EXPRESSION; GENE ONTOLOGY; GENETIC ANALYSIS; GENETICALLY ATTENUATED PARASITE; HEPATOBILIARY PARAMETERS; LIVER STAGE; MICROBIAL GENE; NONHUMAN; PLASMODIUM; PLASMODIUM (LIFE CYCLE STAGE); PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSGENIC ORGANISM; APOPTOSIS; BIOLOGY; GENE EXPRESSION PROFILING; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; LIFE CYCLE STAGE; LIVER; MALARIA; METABOLISM; MOLECULAR GENETICS; PARASITOLOGY; PROCEDURES; PROTEOMICS;

APOPTOSIS; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; HUMANS; LIFE CYCLE STAGES; LIVER; MALARIA; MALARIA VACCINES; METABOLIC NETWORKS AND PATHWAYS; MOLECULAR SEQUENCE ANNOTATION; PLASMODIUM; PROTEOME; PROTEOMICS; PROTOZOAN PROTEINS; TRANSCRIPTOME; VACCINES, ATTENUATED;

EID: 84941893969     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2015.09.002     Document Type: Article

References (89)

1. Acharya P., Pallavi R., Chandran S., Chakravarti H., Middha S., Acharya J., Kochar S., Kochar D., Subudhi A., Boopathi A.P. A glimpse into the clinical proteome of human malaria parasites Plasmodium falciparum and Plasmodium vivax. Proteomics Clin. Appl. 2009, 3:1314-1325.
2. Agnandji S.T., Lell B., Fernandes J.F., Abossolo B.P., Methogo B., Kabwende A.L., Adegnika A.A., Mordmueller B., Issifou S. A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants. N. Engl. J. Med. 2012, 367:2284-2295.
3. Alings F., Sarin L.P., Fufezan C., Drexler H.C., Leidel S.A. An evolutionary approach uncovers a diverse response of tRNA 2-thiolation to elevated temperatures in yeast. RNA 2015, 21:202-212.
4. Annoura T., van Schaijk B.C., Ploemen I.H., Sajid M., Lin J.-w., Vos M.W., Dinmohamed A.G., Inaoka D.K., Rijpma S.R., van Gemert G.-J. Two Plasmodium 6-Cys family-related proteins have distinct and critical roles in liver-stage development. FASEB J. 2014, 28:2158-2170.
5. Aurrecoechea C., Brestelli J., Brunk B.P., Dommer J., Fischer S., Gajria B., Gao X., Gingle A., Grant G., Harb O.S. PlasmoDB: a functional genomic database for malaria parasites. Nucleic Acids Res. 2009, 37:D539-D543.
6. Behal R., Buxton D., Robertson J., Olson M. Regulation of the pyruvate dehydrogenase multienzyme complex. Annu. Rev. Nutr. 1993, 13:497-520.
7. Behet M.C., Foquet L., van Gemert G.-J., Bijker E.M., Meuleman P., Leroux-Roels G., Hermsen C.C., Scholzen A., Sauerwein R.W. Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum. Malar. J. 2014, 13:136.
8. Bowyer P.W., Simon G.M., Cravatt B.F., Bogyo M. Global profiling of proteolysis during rupture of Plasmodium falciparum from the host erythrocyte. Mol. Cell. Proteomics 2011, 10. (M110. 001636).
9. Brown R.M., Head R.A., Boubriak I.I., Leonard J.V., Thomas N.H., Brown G.K. Mutations in the gene for the E1β subunit: a novel cause of pyruvate dehydrogenase deficiency. Hum. Genet. 2004, 115:123-127.
10. Butler N.S., Vaughan A.M., Harty J.T., Kappe S.H. Whole parasite vaccination approaches for prevention of malaria infection. Trends Immunol. 2012, 33:247-254.
11. Chen F., Mackey A.J., Stoeckert C.J., Roos D.S. OrthoMCL-DB: querying a comprehensive multi-species collection of ortholog groups. Nucleic Acids Res. 2006, 34:D363-D368.
12. Chen L., Wang Y., Ma D., Chen Y. Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax overexpression. Apoptosis 2006, 11:101-111.
13. Chun K., MacKay N., Petrova-Benedict R., Robinson B.H. Mutations in the X-linked E1α subunit of pyruvate dehydrogenase leading to deficiency of the pyruvate dehydrogenase complex. Hum. Mol. Genet. 1993, 2:449-454.
14. Clyde D.F., Most H., McCarthy V.C., Vanderberg J.P. Immunization of man against sporozite-induced falciparum malaria. Am. J. Med. Sci. 1973, 266:169-177.
15. Cronan John E., Rock Charles O. Biosynthesis of membrane lipids. Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed 1996, 612-636. ASM Press, Washington, DC.
16. Dang W., Zhang M., Sun L. Edwardsiella tarda DnaJ is a virulence-associated molecular chaperone with immunoprotective potential. Fish Shellfish Immunol. 2011, 31:182-188.
17. De Niz M., Helm S., Horstmann S., Annoura T., del Portillo H.A., Khan S.M., Heussler V.T. In vivo and in vitro characterization of a Plasmodium liver stage-specific promoter. PLoS One 2015, 10.
18. Florens L., Washburn M.P., Raine J.D., Anthony R.M., Grainger M., Haynes J.D., Moch J.K., Muster N., Sacci J.B., Tabb D.L. A proteomic view of the Plasmodium falciparum life cycle. Nature 2002, 419:520-526.
19. Florens L., Liu X., Wang Y., Yang S., Schwartz O., Peglar M., Carucci D.J., Yates J.R., Wu Y. Proteomics approach reveals novel proteins on the surface of malaria-infected erythrocytes. Mol. Biochem. Parasitol. 2004, 135:1-11.
20. Foth B.J., Stimmler L.M., Handman E., Crabb B.S., Hodder A.N., McFadden G.I. The malaria parasite Plasmodium falciparum has only one pyruvate dehydrogenase complex, which is located in the apicoplast. Mol. Microbiol. 2005, 55:39-53.
21. Hartl F.U., Hayer-Hartl M. Converging concepts of protein folding in vitro and in vivo. Nat. Struct. Mol. Biol. 2009, 16:574-581.
22. Haussig J.M., Matuschewski K., Kooij T.W. Inactivation of a Plasmodium apicoplast protein attenuates formation of liver merozoites. Mol. Microbiol. 2011, 81:1511-1525.
23. Helm S., Lehmann C., Nagel A., Stanway R.R., Horstmann S., Llinas M., Heussler V.T. Identification and characterization of a liver stage-specific promoter region of the malaria parasite Plasmodium. PLoS One 2010, 5:e13653.
24. Henderson P.J., Lardy H.A. Bongkrekic acid an inhibitor of the adenine nucleotide translocase of mitochondria. J. Biol. Chem. 1970, 245:1319-1326.
25. Kaiser K., Matuschewski K., Camargo N., Ross J., Kappe S.H. Differential transcriptome profiling identifies Plasmodium genes encoding pre-erythrocytic stage-specific proteins. Mol. Microbiol. 2004, 51:1221-1232.
26. Khan M.N., Bansal A., Shukla D., Paliwal P., Sarada S., Mustoori S.R., Banerjee P.K. Immunogenicity and protective efficacy of DnaJ (hsp40) of Streptococcus pneumoniae against lethal infection in mice. Vaccine 2006, 24:6225-6231.
27. Khan S.M., Janse C.J., Kappe S.H., Mikolajczak S.A. Genetic engineering of attenuated malaria parasites for vaccination. Curr. Opin. Biotechnol. 2012, 23:908-916.
28. Kumar A., Tanveer A., Biswas S., Ram E.V., Gupta A., Kumar B., Habib S. Nuclear-encoded DnaJ homologue of Plasmodium falciparum interacts with replication ori of the apicoplast genome. Mol. Microbiol. 2010, 75:942-956.
29. Labaied M., Harupa A., Dumpit R.F., Coppens I., Mikolajczak S.A., Kappe S.H. Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection. Infect. Immun. 2007, 75:3758-3768.
30. Lacroix C., Giovannini D., Combe A., Bargieri D.Y., Späth S., Panchal D., Tawk L., Thiberge S., Carvalho T.G., Barale J.-C. FLP/FRT-mediated conditional mutagenesis in pre-erythrocytic stages of Plasmodium berghei. Nat. Protoc. 2011, 6:1412-1428.
31. Lasonder E., Janse C.J., van Gemert G.-J., Mair G.R., Vermunt A.M., Douradinha B.G., van Noort V., Huynen M.A., Luty A.J., Kroeze H. Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity. PLoS Pathog. 2008, 4:e1000195.
32. Laurentino E.C., Taylor S., Mair G.R., Lasonder E., Bartfai R., Stunnenberg H.G., Kroeze H., Ramesar J., Franke-Fayard B., Khan S.M. Experimentally controlled downregulation of the histone chaperone FACT in Plasmodium berghei reveals that it is critical to male gamete fertility. Cell. Microbiol. 2011, 13:1956-1974.
33. Leidel S., Pedrioli P.G., Bucher T., Brost R., Costanzo M., Schmidt A., Aebersold R., Boone C., Hofmann K., Peter M. Ubiquitin-related modifier Urm1 acts as a sulphur carrier in thiolation of eukaryotic transfer RNA. Nature 2009, 458:228-232.
34. Letunic I., Doerks T., Bork P. SMART 7: recent updates to the protein domain annotation resource. Nucleic Acids Res. 2012, 40:D302-D305.
35. Liao Z., Chen X., Nie D., Wang J., Wu M. A RING finger protein 114 (RNF114) homolog from Chinese sturgeon (Acipenser sinensis) possesses immune-regulation properties via modulating RIG-I signaling pathway-mediated interferon expression. Fish Shellfish Immunol. 2014, 41:507-516.
36. Lin M., Behal R., Oliver D.J. Disruption of plE2, the gene for the E2 subunit of the plastid pyruvate dehydrogenase complex, in Arabidopsis causes an early embryo lethal phenotype. Plant Mol. Biol. 2003, 52:865-872.
37. Lindner S.E., Swearingen K.E., Harupa A., Vaughan A.M., Sinnis P., Moritz R.L., Kappe S.H. Total and putative surface proteomics of malaria parasite salivary gland sporozoites. Mol. Cell. Proteomics 2013, 12:1127-1143.
38. Lipkowitz S., Weissman A.M. RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat. Rev. Cancer 2011, 11:629-643.
39. Logan-Klumpler F.J., De Silva N., Boehme U., Rogers M.B., Velarde G., McQuillan J.A., Carver T., Aslett M., Olsen C., Subramanian S. GeneDB-an annotation database for pathogens. Nucleic Acids Res. 2012, 40:D98-D108.
40. Ludewig M.H., Boshoff A., Horn D., Blatch G.L. Trypanosoma Brucei J Protein 2 is a Stress Inducible and Essential Hsp40 2015, The International Journal of Biochemistry & Cell Biology.
41. Martinis S.A., Plateau P., Cavarelli J., Florentz C. Aminoacyl-tRNA synthetases: a family of expanding functions Mittelwihr, France, October 10-15, 1999. EMBO J. 1999, 18:4591-4596.
42. Matuschewski K., Ross J., Brown S.M., Kaiser K., Nussenzweig V., Kappe S.H. Infectivity-associated changes in the transcriptional repertoire of the malaria parasite sporozoite stage. J. Biol. Chem. 2002, 277:41948-41953.
43. Miao J., Fan Q., Cui L., Li X., Wang H., Ning G., Reese J.C., Cui L. The MYST family histone acetyltransferase regulates gene expression and cell cycle in malaria parasite Plasmodium falciparum. Mol. Microbiol. 2010, 78:883-902.
44. Mikolajczak S.A., Lakshmanan V., Fishbaugher M., Camargo N., Harupa A., Kaushansky A., Douglass A.N., Baldwin M., Healer J., O'Neill M. A Next Generation Genetically Attenuated Plasmodium falciparum Parasite Created by Triple Gene Deletion 2014, Molecular Therapy.
45. Mueller A.-K., Labaied M., Kappe S.H., Matuschewski K. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 2004, 433:164-167.
46. Mueller A.-K., Camargo N., Kaiser K., Andorfer C., Frevert U., Matuschewski K., Kappe S.H. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:3022-3027.
47. Nagel A., Prado M., Heitmann A., Tartz S., Jacobs T., Deschermeier C., Helm S., Stanway R., Heussler V. A new approach to generate a safe double-attenuated Plasmodium liver stage vaccine. Int. J. Parasitol. 2013, 43:503-514.
48. Nussenzweig R., Vanderberg J., Most H., Orton C. Protective Immunity Produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei 1967.
49. Oehring S.C., Woodcroft B.J., Moes S., Wetzel J., Dietz O., Pulfer A., Dekiwadia C., Maeser P., Flueck C., Witmer K. Organellar proteomics reveals hundreds of novel nuclear proteins in the malaria parasite Plasmodium falciparum. Genome Biol. 2012, 13:R108.
50. Orito Y., Ishino T., Iwanaga S., Kaneko I., Kato T., Menard R., Chinzei Y., Yuda M. Liver-specific protein 2: a Plasmodium protein exported to the hepatocyte cytoplasm and required for merozoite formation. Mol. Microbiol. 2013, 87:66-79.
51. Otto T.D., Böhme U., Jackson A.P., Hunt M., Franke-Fayard B., Hoeijmakers W.A., Religa A.A., Robertson L., Sanders M., Ogun S.A. A comprehensive evaluation of rodent malaria parasite genomes and gene-expression. BMC Biol. 2014, 12:86.
52. Pease B.N., Huttlin E.L., Jedrychowski M.P., Talevich E., Harmon J., Dillman T., Kannan N., Doerig C., Chakrabarti R., Gygi S.P. Global analysis of protein expression and phosphorylation of three stages of Plasmodium falciparum intraerythrocytic development. J. Proteome Res. 2013, 12:4028-4045.
53. Pei Y., Tarun A.S., Vaughan A.M., Herman R.W., Soliman J., Erickson-Wayman A., Kappe S.H. Plasmodium pyruvate dehydrogenase activity is only essential for the parasite's progression from liver infection to blood infection. Mol. Microbiol. 2010, 75:957-971.
54. Pfeil J., Sepp K.J., Heiss K., Meister M., Mueller A.-K., Borrmann S. Protection against malaria by immunization with non-attenuated sporozoites under single-dose piperaquine-tetraphosphate chemoprophylaxis. Vaccine 2014, 32:6005-6011.
55. Piepersberg W., Böck A., Yaguchi M., Wittmann H. Genetic position and amino acid replacements of several mutations in ribosomal protein S5 from Escherichia coli. Mol. Gen. Genet. MGG 1975, 143:43-52.
56. Prudêncio M., Rodriguez A., Mota M.M. The silent path to thousands of merozoites: the Plasmodium liver stage. Nat. Rev. Microbiol. 2006, 4:849-856.
57. Quemard A., Sacchettini J.C., Dessen A., Vilcheze C., Bittman R., Jacobs W.R., Blanchard J.S. Enzymic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry 1995, 34:8235-8241.
58. Roestenberg M., McCall M., Hopman J., Wiersma J., Luty A.J., van Gemert G.J., van de Vegte-Bolmer M., van Schaijk B., Teelen K., Arens T. Protection against a malaria challenge by sporozoite inoculation. N. Engl. J. Med. 2009, 361:468-477.
59. Rug M., Cyrklaff M., Mikkonen A., Lemgruber L., Kuelzer S., Sanchez C.P., Thompson J., Hanssen E., O'Neill M., Langer C. Export of virulence proteins by malaria-infected erythrocytes involves remodeling of host actin cytoskeleton. Blood 2014, 124:3459.
60. Sahu T., Boisson B., Lacroix C., Bischoff E., Richier Q., Formaglio P., Thiberge S., Dobrescu I., Ménard R., Baldacci P. ZIPCO, a putative metal ion transporter, is crucial for Plasmodium liver-stage development. EMBO Mol. Med. 2014, 6:1387-1397.
61. Schnick C., Polley S.D., Fivelman Q.L., Ranford-Cartwright L.C., Wilkinson S.R., Brannigan J.A., Wilkinson A.J., Baker D.A. Structure and non-essential function of glycerol kinase in Plasmodium falciparum blood stages. Mol. Microbiol. 2009, 71:533-545.
62. Sharma A., Yogavel M., Akhouri R.R., Gill J., Sharma A. Crystal structure of soluble domain of malaria sporozoite protein UIS3 in complex with lipid. J. Biol. Chem. 2008, 283:24077-24088.
63. Sievers F., Wilm A., Dineen D., Gibson T.J., Karplus K., Li W., Lopez R., McWilliam H., Remmert M., Söding J. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 2011, 7.
64. Silvestrini F., Lasonder E., Olivieri A., Camarda G., van Schaijk B., Sanchez M., Younis S.Y., Sauerwein R., Alano P. Protein export marks the early phase of gametocytogenesis of the human malaria parasite Plasmodium falciparum. Mol. Cell. Proteomics 2010, 9:1437-1448.
65. Silvie O., Goetz K., Matuschewski K. A sporozoite asparagine-rich protein controls initiation of Plasmodium liver stage development. PLoS Pathog. 2008, 4:e1000086.
66. Singh A.P., Buscaglia C.A., Wang Q., Levay A., Nussenzweig D.R., Walker J.R., Winzeler E.A., Fujii H., Fontoura B.M., Nussenzweig V. Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite. Cell 2007, 131:492-504.
67. Solyakov L., Halbert J., Alam M.M., Semblat J.-P., Dorin-Semblat D., Reininger L., Bottrill A.R., Mistry S., Abdi A., Fennell C. Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum. Nat. Commun. 2011, 2:565.
68. Spring M., Murphy J., Nielsen R., Dowler M., Bennett J.W., Zarling S., Williams J., de la Vega P., Ware L., Komisar J. First-in-human evaluation of genetically attenuatedPlasmodium falciparumsporozoites administered by bite of Anopheles mosquitoes to adult volunteers. Vaccine 2013, 31:4975-4983.
69. Stanway R.R., Witt T., Zobiak B., Aepfelbacher M., Heussler V.T. GFP-targeting allows visualization of the apicoplast throughout the life cycle of live malaria parasites. Biol. Cell. 2009, 101:415-435.
70. Sugden M.C., Holness M.J. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. Am. J. Physiol. Endocrinol. Metab. 2003, 284:E855-E862.
71. Tarun A.S., Peng X., Dumpit R.F., Ogata Y., Silva-Rivera H., Camargo N., Daly T.M., Bergman L.W., Kappe S.H. A combined transcriptome and proteome survey of malaria parasite liver stages. Proc. Natl. Acad. Sci. 2008, 105:305-310.
72. Tracy C.M., Gray A.J., Cuéllar J., Shaw T.S., Howlett A.C., Taylor R.M., Prince J.T., Ahn N.G., Valpuesta J.M., Willardson B.M. Programmed cell death protein 5 interacts with the cytosolic chaperonin containing tailless complex polypeptide 1 (CCT) to regulate β-tubulin folding. J. Biol. Chem. 2014, 289:4490-4502.
73. Treeck M., Sanders J.L., Elias J.E., Boothroyd J.C. The phosphoproteomes ofPlasmodium falciparumandToxoplasma gondiireveal unusual adaptations within and beyond the parasites' boundaries. Cell Host Microbe 2011, 10:410-419.
74. Van Dijk M., Waters A., Janse C. Stable transfection of malaria parasite blood stages. Science 1995, 268:1358-1362.
75. van Dooren G.G., Marti M., Tonkin C.J., Stimmler L.M., Cowman A.F., McFadden G.I. Development of the endoplasmic reticulum, mitochondrion and apicoplast during the asexual life cycle of Plasmodium falciparum. Mol. Microbiol. 2005, 57:405-419.
76. van Oosten-Hawle P., Morimoto R.I. Transcellular chaperone signaling: an organismal strategy for integrated cell stress responses. J. Exp. Biol. 2014, 217:129-136.
77. van Schaijk B.C., Ploemen I.H., Annoura T., Vos M.W., Foquet L., van Gemert G.-J., Chevalley-Maurel S., van de Vegte-Bolmer M., Sajid M., Franetich J.-F. A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoites. Elife 2014, 3:e03582.
78. Vaughan A.M., O'Neill M.T., Tarun A.S., Camargo N., Phuong T.M., Aly A.S., Cowman A.F., Kappe S.H. Type II fatty acid synthesis is essential only for malaria parasite late liver stage development. Cell. Microbiol. 2009, 11:506-520.
79. Vaughan A., Wang R., Kappe S.H. Genetically engineered, attenuated whole-cell vaccine approaches for malaria. Hum. Vaccin. 2010, 6:107-113.
80. Waterhouse A.M., Procter J.B., Martin D.M., Clamp M., Barton G.J. Jalview version 2 - a multiple sequence alignment editor and analysis workbench. Bioinformatics 2009, 25:1189-1191.
81. Waters A., Mota M., Van Dijk M., Janse C. Malaria vaccines: back to the future?. Science (Wash.) 2005, 307:528-530.
82. Wells T.N., Alonso P.L., Gutteridge W.E. New medicines to improve control and contribute to the eradication of malaria. Nat. Rev. Drug Discov. 2009, 8:879-891.
83. Witteveen C.F., van de Vondervoort P., Dijkema C., Swart K., Visser J. Characterization of a glycerol kinase mutant of Aspergillus niger. J. Gen. Microbiol. 1990, 136:1299-1305.
84. WorldHealthOrganization Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine-using countries. Wkly Epidemiol. Rec. 2003, 78:241-250.
85. WorldHealthOrganization BCG vaccine. WHO position paper. Wkly. Epidemiol. Rec. 2004, 79:27.
86. WorldHealthOrganization Measles vaccines: WHO position paper. Wkly Epidemiol. Rec. 2009, 84:349-360.
87. Xu L., Chen Y., Song Q., Xu D., Wang Y., Ma D. PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis. Neoplasia 2009, 11:345-IN342.
88. Yano K., Komaki-Yasuda K., Tsuboi T., Torii M., Kano S., Kawazu S.-i. 2-Cys Peroxiredoxin TPx-1 is involved in gametocyte development in Plasmodium berghei. Mol. Biochem. Parasitol. 2006, 148:44-51.
89. Yu M., Kumar T., Nkrumah L.J., Coppi A., Retzlaff S., Li C.D., Kelly B.J., Moura P.A., Lakshmanan V., Freundlich J.S. The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasites. Cell Host Microbe 2008, 4:567-578.